- Filed
- Oct 5, 2022 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2022 · Mar 31, 2022 | 17.55M sh |
| Capex | FY 2022 · Mar 31, 2022 | $0 |
| Capex | FY 2022 · Mar 31, 2021 | $5.63K |
| Operating Cash Flow restated | FY 2022 · Mar 31, 2022 | −$396.97K |
| Operating Cash Flow | FY 2022 · Mar 31, 2021 | $309.2K |
| Short Term Debt | FY 2022 · Mar 31, 2022 | $462.03K |
| Short Term Debt | FY 2022 · Mar 31, 2021 | $402.25K |
| Cash And Equivalents restated | FY 2022 · Mar 31, 2022 | $101.72K |
| Cash And Equivalents | FY 2022 · Mar 31, 2021 | $194.59K |
| Cash And Equivalents | FY 2022 · Mar 31, 2020 | $60.79K |
| Stockholders Equity restated | FY 2022 · Mar 31, 2022 | $941.4K |
| Stockholders Equity | FY 2022 · Mar 31, 2021 | $1.5M |
| Stockholders Equity | FY 2022 · Mar 31, 2020 | $1.48M |
| Current Liabilities | FY 2022 · Mar 31, 2022 | $835.57K |
| Current Liabilities | FY 2022 · Mar 31, 2021 | $761.24K |
| Total Liabilities | FY 2022 · Mar 31, 2022 | $1.91M |
| Total Liabilities | FY 2022 · Mar 31, 2021 | $1.96M |
| Current Assets | FY 2022 · Mar 31, 2022 | $2.08M |
| Current Assets | FY 2022 · Mar 31, 2021 | $2.44M |
| Total Assets | FY 2022 · Mar 31, 2022 | $2.85M |
| Total Assets | FY 2022 · Mar 31, 2021 | $3.46M |
| Sga Expense restated | FY 2022 · Mar 31, 2022 | $1.04M |
| Sga Expense | FY 2022 · Mar 31, 2021 | $574.63K |
| Rd Expense | FY 2022 · Mar 31, 2022 | $680.31K |
| Rd Expense | FY 2022 · Mar 31, 2021 | $211.04K |
| Net Income | FY 2022 · Mar 31, 2022 | −$1.13M |
| Net Income | FY 2022 · Mar 31, 2021 | −$28.02K |
| Operating Income restated | FY 2022 · Mar 31, 2022 | −$1.13M |
| Operating Income | FY 2022 · Mar 31, 2021 | −$14.6K |
| Gross Profit restated | FY 2022 · Mar 31, 2022 | $1.48M |
| Gross Profit | FY 2022 · Mar 31, 2021 | $1.35M |
| Cost Of Revenue restated | FY 2022 · Mar 31, 2022 | $846.97K |
| Cost Of Revenue restated | FY 2022 · Mar 31, 2021 | $281.96K |